Figure 1.
Monitoring costs to fully vaccinate a child requires monitoring the costs of both vaccine procurement and the costs of providing immunization programs.
Figure 2.
Richest 40 countries in 2009 based on gross domestic product (GDP) per capita measured in current US$.
Figure 3.
Sub-categories of bilateral official development assistance in 2009 for the 23 Development Assistance Committee (DAC) countries as a share of their gross domestic product (GDP) in current 2009 US$.
Figure 4.
Bilateral official development assistance (ODA) allocated for infectious disease control and contributions to the GAVI Alliance (GAVI) in 2009 for the 23 Development Assistance Committee (DAC) countries as a share of their gross domestic product (GDP) in current 2009 US$.
Countries ranked according to total bilateral ODA as a proportion of GDP disbursed in 2009.
Table 1.
Estimated costs of achieving WHO-UNICEF Global Immunization Vision and Strategy by scaling up use of traditional, underused and new vaccines in GAVI-eligible and low- and lower-middle income countries [14] and extrapolated costs for upper-middle-income and Development Assistance Committee (DAC) countries as percentage of 2009 gross domestic product (GDP) measured in current US$.
Figure 5.
Example of a score card to show how Norway is performing relative to other countries for its Vaccine Procurement Assistance, defined as “grant aid provided by national donor governments to procure vaccines as a share of gross domestic product (GDP)”.
Figure 6.
Example of a score card to show how a country of any income status is “under-performing” relative to others for the metric Vaccine Procurement Baseline, defined as “share of gross domestic product spent on vaccine procurement”.